Thermo Fisher Scientific Releases Next Generation CE-IVD Marked TaqPath COVID-19 2.0 Test

Thermo Fisher Scientific, the global leader in science, today announced the launch of a new CE-IVD marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands Thermo Fisher’s range of high-precision tests for the detection of active SARS-CoV-2 infections.

The kit uses an advanced assay design that compensates for current and emerging variants by using a total of eight targets in three genomic regions of the virus. This approach helps the test to produce accurate results even as the virus that causes COVID-19 continues to mutate.

“COVID-19 variants can be more easily transmissible and potentially affect the effectiveness of diagnostics, vaccines and therapies, which risks undoing the advances made over the past year,” said Manoj Gandhi , MD, Ph.D. , Senior Medical Director, Genetic Sciences at Thermo Fisher . “We are working to enable our customers to prepare for the next phase of the pandemic by future proofing our test design against likely mutations and by continuing to give them confidence in their results . “

The TaqPath COVID-19 Fast PCR Combo Kit 2.0 test evaluates raw saliva directly with a processing time of two hours to enable widespread, high-frequency testing. The first generation TaqPath COVID-19 CE-IVD RT PCR Kit and TaqPath COVID-19 Combo Kit, each using a different assay design, received the first CE-IVD certification and Emergency Use Authorization from the US in March 2020 – American Food and Drug Administration (FDA).

For more information on the TaqPath platform, please visit: www.thermofisher.com/covid19evolved

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world’s leading science service company, with annual sales exceeding $ 30 billion. Our mission is to empower our customers to make the world healthier, cleaner and safer. Regardless of whether our customers want to accelerate research in the life sciences, solve complex analytical challenges, improve diagnostics and therapies for patients or increase productivity in their laboratories – we are there for them. Our global team of more than 80,000 colleagues offers an unmatched combination of innovative technology, shopping convenience and pharmaceutical services through our industry-leading brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. www.thermofisher.com .

Media contactsMauricio MinottaHead of Press and Public RelationsAriane LovellFinn Partners
Tel .: +1 760-929-2456Tel .: +1 646-307-6317
E-mail:  [email protected]E-mail:  [email protected]

Related links

http://www.thermofisher.com

SOURCE Thermo Fisher Scientific

Leave a Reply

Your email address will not be published. Required fields are marked *